Wojcik DP, Godfrey ME, Christie D, Haley BE. Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994–2006). Neuro Endocrinology Letters. 2006 Aug;27(4):415-423.
Chronic fatigue, foggy memory, and depression bring people to primary care every week—and the cause is not always obvious. A New Zealand general-practice team followed patients over a decade to ask whether chronic mercury toxicity (CMT)—often linked to dental amalgam and other exposures—clustered with these symptoms, and whether protected amalgam removal plus medical care changed outcomes.
What the study found
Group One included 465 patients diagnosed with CMT (mean age 45.1, mean 10.2 amalgams / 25.2 surfaces). Among them:
- 32.3% met criteria for chronic fatigue syndrome
- 88.8% reported memory loss (plus 1.3% with physician-diagnosed Alzheimer’s dementia)
- 27.5% had depression meeting medication-history criteria
A second cohort of 864 consecutive general-practice patients found 30.3% with clinical evidence consistent with CMT. In both settings, CMT correlated significantly with the APO-E4 genotype (p = 0.001 / p < 0.001 depending on analysis).
Among the first 170 patients followed (mean 41.6 months), combined dental and medical treatment cut overall symptom scores to about 45% of baseline (p < 0.001); untreated patients did not improve. In 26 patients with paired DMPS tests, urine mercury fell from 422.3 to 44.2 µg Hg/g creatinine (p < 0.001).
[Note: Observational general-practice series, not a randomized trial—associations do not prove amalgam causes every case of fatigue or depression.]
Why it matters for SMART
SMART is the how of amalgam removal—rubber dam, high-volume suction with water, air filtration, PPE—so patients and teams are not acutely overloaded while fillings come out. Wojcik and colleagues pair that dental step with medical follow-up and show that, in their CMT cohort, protected removal plus detoxification tracked with large, sustained symptom drops and lower provoked urine mercury—supporting coordinated dentist–physician care rather than unprotected drilling.
Practical takeaways
- Take multi-system symptoms seriously — Fatigue, memory loss, and depression were common in the CMT cohort.
- Ask about amalgam and other Hg sources — Dental fillings were one exposure pathway among several listed.
- Insist on SMART-style removal — The treated group used a “safe proven protocol,” not casual drilling.
- Coordinate medical care — Chelation/detox regimens in the study were physician-supervised—not DIY.
- Discuss genetics carefully — APO-E4 was associated with CMT; genotyping is a clinical tool, not a standalone diagnosis.
Bottom line: In a large New Zealand practice series, chronic mercury toxicity frequently presented with fatigue, memory impairment, and depression; APO-E4 tracked with susceptibility; and protected amalgam removal plus appropriate treatment produced significant, durable symptom reduction—reinforcing why SMART removal belongs inside a broader mercury-aware care plan.